UPDATED 08.12.2010 13:54

Organised cervical cancer screening programme in the Helsinki region in Finland in the invitation year 2008. Numbers and percentage distribution of primary screening test results, referrals for further examinations, and histological diagnosis of the cervix uteri.

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 55795 719 1.29 2 0.00 2 0.00 7 0.01 46 0.08 129 0.23 69 0.12 464 0.83
I 50261 - - - - - - - - - - - - - - - -
II 4944 144 0.26 - - - - - - 3 0.01 3 0.01 15 0.03 123 0.22
III 553 541 0.97 1 - 1 - 3 0.01 29 0.05 120 0.22 51 0.09 336 0.60
IV 33 33 0.06 1 - 1 - 4 0.01 14 0.03 6 0.01 3 0.01 4 0.01
V 1 1 - - - - - - - - - - - - - 1 -
Inadequate 3 - - - - - - - - - - - - - - - -
HPV test 15916 403 2.53 - - - - 9 0.06 26 0.16 78 0.49 34 0.21 256 1.61
Negative1 14288 4 0.03 - - - - - - - - 1 0.01 - - 3 0.02
Positive2 1628 399 2.51 - - - - 9 0.06 26 0.16 77 0.48 34 0.21 253 1.59
Total 71711 1122 1.56 2 0.00 2 0.00 16 0.02 72 0.10 207 0.29 103 0.14 720 1.00

1 Women with Papanicolaou class I or II negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.